- Home
- IPSC vs SNAL Comparison
IPSC vs SNAL Comparison
Compare IPSC & SNAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPSC
- SNAL
- Stock Information
- Founded
- IPSC 2019
- SNAL 2000
- Country
- IPSC United States
- SNAL United States
- Employees
- IPSC N/A
- SNAL N/A
- Industry
- IPSC Medicinal Chemicals and Botanical Products
- SNAL Computer Software: Prepackaged Software
- Sector
- IPSC Health Care
- SNAL Technology
- Exchange
- IPSC Nasdaq
- SNAL Nasdaq
- Market Cap
- IPSC 48.2M
- SNAL 40.0M
- IPO Year
- IPSC 2021
- SNAL 2022
- Fundamental
- Price
- IPSC $0.53
- SNAL $0.89
- Analyst Decision
- IPSC Strong Buy
- SNAL
- Analyst Count
- IPSC 5
- SNAL 0
- Target Price
- IPSC $3.33
- SNAL N/A
- AVG Volume (30 Days)
- IPSC 719.1K
- SNAL 33.7K
- Earning Date
- IPSC 05-15-2025
- SNAL 05-14-2025
- Dividend Yield
- IPSC N/A
- SNAL N/A
- EPS Growth
- IPSC N/A
- SNAL N/A
- EPS
- IPSC N/A
- SNAL 0.04
- Revenue
- IPSC $114,898,000.00
- SNAL $90,462,190.00
- Revenue This Year
- IPSC $833.10
- SNAL $21.96
- Revenue Next Year
- IPSC N/A
- SNAL $22.77
- P/E Ratio
- IPSC N/A
- SNAL $23.67
- Revenue Growth
- IPSC 8286.72
- SNAL 46.95
- 52 Week Low
- IPSC $0.34
- SNAL $0.52
- 52 Week High
- IPSC $3.46
- SNAL $3.42
- Technical
- Relative Strength Index (RSI)
- IPSC 46.73
- SNAL 40.02
- Support Level
- IPSC $0.48
- SNAL $0.85
- Resistance Level
- IPSC $0.59
- SNAL $0.97
- Average True Range (ATR)
- IPSC 0.04
- SNAL 0.07
- MACD
- IPSC -0.00
- SNAL -0.00
- Stochastic Oscillator
- IPSC 34.62
- SNAL 11.46
About IPSC Century Therapeutics Inc.
Century Therapeutics Inc is a biotechnology company that specializes in leveraging adult stem cells to develop cell therapy products aimed at treating cancer, autoimmune disorders, and inflammatory diseases. Their features a genetically engineered allogeneic cell therapy platform that incorporates induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and manufacturing capabilities. This comprehensive platform seeks to address the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and reducing development and supply risks.
About SNAL Snail Inc.
Snail Inc is an independent developer and publisher of interactive digital entertainment for consumers around the world, with a portfolio of premium games designed for use on a variety of platforms, including consoles, PC's, and mobile devices. The geographic presence of the company is in the United States and the International market, where the majority of its revenue comes from the United States.